iFR Uncovers Profound But Mostly Reversible Ischemia in CTOs and Helps to Optimize PCI Results | SCAI
Jun 17th 2020 | News & Clinical Trials

iFR Uncovers Profound But Mostly Reversible Ischemia in CTOs and Helps to Optimize PCI Results

Acute Coronary Syndromes (ACS) Cardio-oncology CHIP/Complex PCI CTO Heart Failure Hemodynamic Support Hypertrophic Cardiomyopathy Left Main Bifurcation SIHD

From Catheterization & Cardiovascular Interventions

Authors: Peter Kayaert, MD; Mathieu Coeman, MD; Benny Drieghe, MD; Johan Bennett, MD, PhD; Keir McCutcheon, MD, PhD; Jo Dens MD, PhD; Claudiu Ungureanu, MD; Carlo Zivelonghi, MD; Pierfrancesco Agostoni, MD, PhD; Yoann Bataille, MD, PhD; Quentin de Hemptinne, MD; Sofie Gevaert, MD, PhD; Michel De Pauw, MD, PhD; and Steven Haine MD, PhD.